openPR Logo
Press release

Investigation for Investors in NYSE: BHC shares announce over possible Wrongdoing at Bausch Health Companies Inc.

06-30-2022 04:47 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing.

An investigation on behalf of investors in Bausch Health Companies Inc. (NYSE: BHC) shares over potential wrongdoing.

Certain directors of Bausch Health Companies Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Bausch Health Companies Inc. (NYSE: BHC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Bausch Health Companies directors breached their fiduciary duties and caused damage to the company and its shareholders.

Canadian based Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.
On April 20, 2022, Bausch Health Companies Inc launched an initial public offering and Eye-Care spinoff, offering 35 million shares at between $21 and $24 per share, with a 30-day underwriter option for up to 5.25 million additional shares. The company will list shares under the ticker symbol BLCO on the New York Stock Exchange and the Toronto Stock Exchange.

Shares of Bausch Health Companies Inc. (NYSE: BHC) declined from $26.22 per share in early February 2022, to as low as $12.81 per share on May 9, 2022.

Those who purchased shares of Bausch Health Companies Inc. (NYSE: BHC) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in NYSE: BHC shares announce over possible Wrongdoing at Bausch Health Companies Inc. here

News-ID: 2666974 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Bausch

Ocular Implants Market 2022 Development Status - Alcon, Inc., Bausch & Lomb
Ocular Implants Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It
Vision Care Market Precise Outlook 2019- Johnson & Johnson, The Cooper Companies …
"Global Vision Care Market: Size, Trends & Forecasts (2019-2023 Edition)"research study is segmented on the basis of applications, technology, geography and types. The report provides a detailed Vision Care Industry Overview along with the analysis of industry's gross margin, cost structure, consumption value, and sale price. The leading companies of the Vision Care Market, manufacturers, and distributors are profiled in the report alongwith the latest Industry development current and future
Vision Care Market 2020 Precise Outlook - Johnson & Johnson, The Cooper Companie …
The Vision Care Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Vision care refers to the
Global Conjunctivitis Market 2018 – Novartis, Santen Pharmaceutical, Bausch + …
The conjunctivitis Market has dominated many regions of the world in recent years. According to the world conjunctivitis market report, it will continue to govern in the coming years. The increasing demand of the conjunctivitis market and the various business opportunities have driven the growth of conjunctivitis. The market for conjunctivitis shows a gradual increase in recent years. Specifies the market forecast of conjunctivitis from 2018 to 2022. To begin with,
Latest Development of Global Elderly and Disabled Assistive Devices Market Repor …
Researchmoz added Most up-to-date research on "Global Elderly and Disabled Assistive Devices Sales Market Report 2018" to its huge collection of research reports. This report studies the global Elderly and Disabled Assistive Devices market status and forecast, categorizes the global Elderly and Disabled Assistive Devices market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast
Artificial Tears Market Trends, Key players (Allergan, Alcon, Bausch)
A new business intelligence report released by HTF MI with title “Global Artificial Tears Market Analysis 2012-2017 and Forecast 2018-2023” that targets and provides comprehensive market analysis with future prospects to 2023. The analysts of the study have garnered extensive research methodologies and data sources (i.e Secondary & Primary Sources) in order to generate collective and useful information that delivers latest market undercurrents and industry trends. Request Sample Report @: